Clinical Trial Update: Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial [NA]

View source ↗

Summary

A completed randomized, placebo-controlled trial evaluating mefloquine as prophylaxis in HIV-1 individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Larium (mefloquine)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: HIV Infections | NA | Status: COMPLETED